mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.002 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.002 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.002 |